CDK14 Inhibition Reduces Mammary Stem Cell Activity and Suppresses Triple Negative Breast Cancer Progression

Scientists investigated the function of cyclin-dependent kinase 14 (CDK14), a member of the Wnt signaling pathway, in mammary development and breast cancer progression.